Zulfiqar Ahmad

Prof. Zulfiqar Ahmad


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2012 in ISRN Microbiology
Verified
Journal Article
Open access
PDF file
MKM. Anaul Kabir
M. Anaul Kabir
MHMohammad Asif Hussain
Mohammad Asif Hussain
ZAZulfiqar Ahmad
Zulfiqar Ahmad
Candida albicansis an opportunistic human fungal pathogen that causes candidiasis. As healthcare has been improved worldwide, the number of immunocompromised patients has been increased to a greater extent and they are highly susceptible to various pathogenic microbes andC. albicanshas been prominent among the fungal pathogens. The complete genome sequence of this pathogen is now available and has been extremely useful for the identification of repertoire of genes present in this pathogen. The major challenge is now to assign the functions to these genes of which 13% are specific toC. albicans. Due to its close relationship with yeastSaccharomyces cerevisiae, an edge over other fungal pathogens because most of the technologies can be directly transferred toC. albicansfromS. cerevisiaeand it is amenable to mutation, gene disruption, and transformation. The last two decades have witnessed enormous amount of research activities on this pathogen that leads to the understanding of host-parasite interaction, infections, and disease propagation. Clearly,C. albicanshas emerged as a model organism for studying fungal pathogens along with other two fungiAspergillus fumigatusandCryptococcus neoformans. Understanding its complete life style ofC. albicanswill undoubtedly be useful for developing potential antifungal drugs and tacklingCandidainfections. This will also shed light on the functioning of other fungal pathogens.

1 July 2009 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
PDPrasanna K. Dadi
Prasanna K. Dadi
MAMubeen Ahmad
Mubeen Ahmad
ZAZulfiqar Ahmad
Zulfiqar Ahmad

1 June 2010 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
NCNagababu Chinnam
Nagababu Chinnam
PDPrasanna K. Dadi
Prasanna K. Dadi
SSShahbaaz A. Sabri
Shahbaaz A. Sabri
MAMubeen Ahmad
Mubeen Ahmad
MKM. Anaul Kabir
M. Anaul Kabir
ZAZulfiqar Ahmad
Zulfiqar Ahmad

24 February 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JMJames L. Martin
James L. Martin
RIRobert Ishmukhametov
Robert Ishmukhametov
THTassilo Hornung
Tassilo Hornung
ZAZulfiqar Ahmad
Zulfiqar Ahmad
WFWayne D. Frasch
Wayne D. Frasch
Significance: We present a description of the angular velocity of the power stroke as a function of rotational position for the F 1 -ATPase molecular motor. The angular velocity of this motor, which rotates in 120° power strokes separated by catalytic dwells, is part of the F o F 1 ATP synthase in oxidative phosphorylation, and has been thought not to vary. This paper reports the unexpected discovery that a series of angular accelerations and decelerations occur, providing direct evidence that angular velocity depends on substrate binding affinity. The data support a model in which rotation is powered by Van der Waals repulsive forces during the final 85° of rotation, consistent with a transition from F 1 structures 2HLD1 and 1H8E (Protein Data Bank).

1 March 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ZAZulfiqar Ahmad
Zulfiqar Ahmad
MSMohammad Salim
Mohammad Salim
MMMahin D. Maines
Mahin D. Maines
Human biliverdin reductase (hBVR) is a serine/threonine kinase that catalyzes reduction of the heme oxygenase (HO) activity product, biliverdin, to bilirubin. A domain of biliverdin reductase (BVR) has primary structural features that resemble leucine zipper proteins. A heptad repeat of five leucines (L(1)--L(5)), a basic domain, and a conserved alanine characterize the domain. In hBVR, a lysine replaces L(3). The secondary structure model of hBVR predicts an alpha-helix-turn-beta-sheet for this domain. hBVR translated by the rabbit reticulocyte lysate system appears on a nondenaturing gel as a single band with molecular mass of approximately 69 kDa. The protein on a denaturing gel separates into two anti-hBVR immunoreactive proteins of approximately 39.9 + 34.6 kDa. The dimeric form, but not purified hBVR, binds to a 100-mer DNA fragment corresponding to the mouse HO-1 (hsp32) promoter region encompassing two activator protein (AP-1) sites. The specificity of DNA binding is suggested by the following: (a) hBVR does not bind to the same DNA fragment with one or zero AP-1 sites; (b) a 56-bp random DNA with one AP-1 site does not form a complex with hBVR; (c) in vitro translated HO-1 does not interact with the 100-mer DNA fragment with two AP-1 sites; (d) mutation of Lys(143), Leu(150), or Leu(157) blocks both the formation of the approximately 69-kDa specimens and hBVR DNA complex formation; and (e) purified preparations of hBVR or hHO-1 do not bind to DNA with two AP-1 sites. The potential significance of the AP-1 binding is suggested by the finding that the response of HO-1, in COS cells stably transfected with antisense hBVR, with 66% reduced BVR activity, to superoxide anion (O(2)()) formed by menadione is attenuated, whereas induction by heme is not affected. We propose a role for BVR in the signaling cascade for AP-1 complex activation necessary for HO-1 oxidative stress response.

1 April 2013 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ZAZulfiqar Ahmad
Zulfiqar Ahmad
FOFlorence Okafor
Florence Okafor
SASofiya Azim
Sofiya Azim
TLThomas F. Laughlin
Thomas F. Laughlin
In this review we discuss the role of ATP synthase as a molecular drug target for natural and synthetic antimicrobial/ antitumor peptides. We start with an introduction of the universal nature of the ATP synthase enzyme and its role as a biological nanomotor. Significant structural features required for catalytic activity and motor functions of ATP synthase are described. Relevant details regarding the presence of ATP synthase on the surface of several animal cell types, where it is associated with multiple cellular processes making it a potential drug target with respect to antimicrobial peptides and other inhibitors such as dietary polyphenols, is also reviewed. ATP synthase is known to have about twelve discrete inhibitor binding sites including peptides and other inhibitors located at the interface of α/β subunits on the F1 sector of the enzyme. Molecular interaction of peptides at the β DEELSEED site on ATP synthase is discussed with specific examples. An inhibitory effect of other natural/synthetic inhibitors on ATP is highlighted to explore the therapeutic roles played by peptides and other inhibitors. Lastly, the effect of peptides on the inhibition of the Escherichia coli model system through their action on ATP synthase is presented.